• Consensus Rating: Buy
  • Consensus Price Target: $98.20
  • Forecasted Upside: 26.20 %
  • Number of Analysts: 18
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.13 (0.17%)

This chart shows the closing price for CNC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Centene Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNC

Analyst Price Target is $98.20
▲ +26.20% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $98.20, with a high forecast of $115.00 and a low forecast of $77.00. The average price target represents a 26.20% upside from the last price of $77.81.

This chart shows the closing price for CNC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 18 polled investment analysts is to buy stock in Centene. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/30/2022ArgusInitiated CoverageBuy$90.00Low
9/22/2022CowenLower Target$108.00 ➝ $101.00Low
9/22/2022CowenLower Target$108.00 ➝ $101.00Low
8/26/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$103.00 ➝ $99.00Low
8/9/2022CowenBoost Target$108.00N/A
7/28/2022BarclaysInitiated CoverageOverweight ➝ Overweight$107.00Low
7/27/2022StephensBoost TargetOutperform$110.00Low
7/27/2022OppenheimerBoost TargetOutperform$110.00Low
7/27/2022Truist FinancialBoost TargetOutperform$102.00 ➝ $110.00Low
7/27/2022Deutsche Bank AktiengesellschaftBoost Target$91.00 ➝ $99.00Low
7/19/2022Credit Suisse GroupSet Target$97.00Low
7/14/2022Jefferies Financial GroupUpgradeHold ➝ Buy$82.00 ➝ $115.00Low
7/14/2022Truist FinancialBoost TargetBuy$100.00 ➝ $102.00Low
6/23/2022Morgan StanleyLower TargetOverweight$112.00 ➝ $103.00Low
6/22/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$88.00 ➝ $91.00Low
6/21/2022Credit Suisse GroupUpgradeNeutral ➝ Outperform$86.00 ➝ $88.00Low
6/16/2022Loop CapitalInitiated CoverageBuy$100.00Low
5/26/2022Sanford C. BernsteinInitiated CoverageOutperform$111.00 ➝ $108.00High
5/26/2022Bank of AmericaDowngradeBuy ➝ Neutral$95.00 ➝ $90.00Medium
5/25/2022Wells Fargo & CompanyLower TargetOverweight$96.00 ➝ $95.00Low
2/9/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$84.00 ➝ $88.00Low
2/9/2022MizuhoBoost TargetNeutral$78.00 ➝ $84.00Medium
1/11/2022Sanford C. BernsteinBoost Target$94.00 ➝ $108.00High
1/7/2022BarclaysInitiated CoverageOverweight ➝ Overweight$95.00Medium
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$94.00 ➝ $96.00High
12/17/2021Morgan StanleyBoost TargetOverweight$86.00 ➝ $109.00Low
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$83.00High
12/13/2021Truist FinancialBoost TargetBuy$90.00 ➝ $94.00Low
12/13/2021Wolfe ResearchBoost TargetOutperform$72.00 ➝ $80.00Low
12/13/2021StephensBoost TargetOverweight ➝ Overweight$82.00 ➝ $102.00Low
12/13/2021Bank of AmericaBoost TargetBuy$85.00 ➝ $93.00Low
12/13/2021OppenheimerBoost TargetOutperform ➝ Outperform$90.00 ➝ $95.00Low
12/13/2021Wells Fargo & CompanyBoost TargetOverweight$88.00 ➝ $90.00Medium
12/13/2021Credit Suisse GroupBoost TargetNeutral ➝ Neutral$75.00 ➝ $86.00Medium
12/13/2021BMO Capital MarketsBoost TargetOutperform ➝ Outperform$93.00 ➝ $100.00Medium
12/13/2021MizuhoBoost TargetNeutral ➝ Neutral$70.00 ➝ $78.00Medium
11/1/2021CitigroupDowngradeBuy ➝ Neutral$77.00Medium
10/27/2021Credit Suisse GroupBoost TargetNeutral$70.00 ➝ $75.00High
10/27/2021Morgan StanleyBoost TargetOverweight$79.00 ➝ $86.00High
9/14/2021Credit Suisse GroupLower TargetNeutral$73.50 ➝ $70.00High
9/14/2021Morgan StanleyLower TargetOverweight$88.00 ➝ $79.00High
9/9/2021CowenInitiated CoverageOutperform$87.00High
9/8/2021MizuhoLower TargetNeutral$75.00 ➝ $67.00Medium
8/31/2021Morgan StanleyLower TargetOverweight$94.00 ➝ $88.00Medium
8/17/2021Roth CapitalInitiated CoverageBuyHigh
8/3/2021Wells Fargo & CompanyLower TargetOverweight$93.00 ➝ $88.00Low
7/9/2021Seaport Res PtnReiterated RatingBuyLow
6/17/2021CitigroupBoost TargetBuy ➝ Buy$80.00 ➝ $86.00Medium
6/17/2021Wells Fargo & CompanyBoost TargetOverweight$87.00 ➝ $93.00High
6/17/2021OppenheimerReiterated RatingBuy$90.00High
6/17/2021BMO Capital MarketsBoost TargetPositive ➝ Outperform$88.00 ➝ $93.00High
6/17/2021MizuhoBoost TargetNeutral$65.00 ➝ $75.00High
6/8/2021Bank of AmericaBoost TargetBuy$75.00 ➝ $85.00Low
5/24/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00N/A
5/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00Low
5/11/2021BMO Capital MarketsBoost TargetOutperform$77.00 ➝ $88.00Medium
5/11/2021StephensUpgradeEqual Weight ➝ Overweight$71.00 ➝ $87.00Medium
4/28/2021BMO Capital MarketsLower Target$88.00 ➝ $77.00Medium
3/15/2021MizuhoInitiated CoverageNeutral$65.00N/A
3/9/2021MizuhoInitiated CoverageNeutral$65.00Low
1/21/2021The Goldman Sachs GroupInitiated CoverageNeutralLow
1/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$75.00 ➝ $72.00Medium
12/21/2020Deutsche Bank AktiengesellschaftLower TargetBuy$83.00 ➝ $77.00Medium
12/14/2020SVB LeerinkLower TargetOutperform$80.00 ➝ $75.00High
11/11/2020Piper SandlerBoost TargetOverweight$83.00 ➝ $89.00Medium
10/28/2020Credit Suisse GroupLower TargetNeutral$72.50 ➝ $67.50Medium
10/28/2020Deutsche Bank AktiengesellschaftLower TargetBuy$87.00 ➝ $83.00High
10/28/2020SVB LeerinkBoost TargetOutperform$78.00 ➝ $80.00High
9/22/2020StephensDowngradeOverweight ➝ Equal WeightMedium
9/22/2020BarclaysBoost TargetOverweight$72.00 ➝ $84.00High
7/29/2020Jefferies Financial GroupLower TargetBuy$85.00 ➝ $83.00Low
7/29/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$80.00 ➝ $87.00Medium
7/1/2020SVB LeerinkInitiated CoverageOutperform$78.00High
6/12/2020OppenheimerInitiated CoverageBuy$90.00Low
4/29/2020Bank of AmericaReiterated RatingBuy$82.00Low
4/29/2020Credit Suisse GroupReiterated RatingHold$72.50Low
4/29/2020CitigroupBoost TargetBuy$70.00 ➝ $81.00High
4/29/2020OppenheimerBoost TargetOutperform$83.00 ➝ $90.00High
4/29/2020Deutsche Bank AktiengesellschaftLower TargetBuy$82.00 ➝ $80.00High
4/28/2020OppenheimerReiterated RatingBuy$83.00High
4/13/2020Morgan StanleyBoost TargetOverweight$85.00 ➝ $89.00Low
4/13/2020SunTrust BanksBoost TargetBuy$85.00 ➝ $90.00High
3/27/2020Morgan StanleyBoost TargetOverweight$82.00 ➝ $85.00Low
3/6/2020Deutsche Bank AktiengesellschaftLower TargetBuy$84.00 ➝ $82.00Medium
2/18/2020Deutsche Bank AktiengesellschaftBoost TargetBuy$68.00 ➝ $84.00High
2/7/2020The Goldman Sachs GroupInitiated CoverageBuy$80.00Low
2/5/2020CitigroupBoost TargetBuy$65.00 ➝ $72.00High
2/5/2020JPMorgan Chase & Co.Initiated CoverageNeutral ➝ Overweight$88.00High
2/5/2020Credit Suisse GroupBoost TargetNeutral$65.00 ➝ $72.50High
2/4/2020OppenheimerInitiated CoverageBuy$83.00High
2/3/2020Evercore ISIInitiated CoverageOutperform$90.00Low
1/28/2020Sanford C. BernsteinBoost TargetTop Pick$84.00 ➝ $103.00High
1/24/2020SunTrust BanksReiterated RatingBuy$77.00 ➝ $85.00Low
1/24/2020Wells Fargo & CompanyBoost TargetOverweight$72.00 ➝ $85.00High
1/8/2020Credit Suisse GroupBoost TargetNeutral$57.00 ➝ $65.00High
1/6/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$72.00High
12/16/2019Piper Jaffray CompaniesReiterated RatingBuy$80.00Medium
12/16/2019BMO Capital MarketsBoost TargetPositive ➝ Outperform$65.00 ➝ $70.00High
10/23/2019Deutsche Bank AktiengesellschaftLower TargetBuy$62.00 ➝ $60.00Low
10/23/2019Credit Suisse GroupLower TargetNeutral$63.00 ➝ $57.00High
9/26/2019Morgan StanleyLower TargetOverweight$64.00 ➝ $62.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$62.00High
8/23/2019Morgan StanleyLower TargetOverweight$71.00 ➝ $64.00Medium
7/12/2019Morgan StanleyLower TargetOverweight$75.00 ➝ $71.00Medium
5/10/2019CitigroupUpgradeNeutral ➝ Buy$69.00Medium
4/24/2019SunTrust BanksLower TargetBuy$80.00Low
4/24/2019Morgan StanleyLower TargetOverweight ➝ Overweight$83.00 ➝ $75.00Low
4/21/2019Cantor FitzgeraldReiterated RatingBuy$83.00Low
3/31/2019CowenReiterated RatingBuy$77.00Low
3/29/2019Credit Suisse GroupLower TargetNeutral ➝ Neutral$76.00 ➝ $63.00Low
2/28/2019CowenInitiated CoverageOutperform$77.00High
2/27/2019Cantor FitzgeraldReiterated RatingBuy$83.00Medium
2/7/2019Jefferies Financial GroupReiterated RatingBuy$76.00Low
2/6/2019OppenheimerLower TargetOutperform$165.00 ➝ $83.00Low
1/14/2019StephensInitiated CoverageOverweight$73.50Medium
12/17/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
12/17/2018Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$72.50 ➝ $82.50High
12/13/2018Cantor FitzgeraldReiterated RatingBuy$72.50High
10/24/2018SVB LeerinkUpgradeMarket Perform ➝ Outperform$79.84High
10/2/2018OppenheimerBoost TargetOutperform ➝ Outperform$73.00 ➝ $79.00Low
9/19/2018Mitsubishi UFJ Financial GroupInitiated CoverageOverweight$85.00Low
9/5/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$69.00 ➝ $87.50Low
9/4/2018Credit Suisse GroupBoost TargetNeutral$67.00 ➝ $76.00Low
7/25/2018Piper Jaffray CompaniesReiterated RatingBuy$76.00Low
7/25/2018Credit Suisse GroupBoost TargetNeutral ➝ Neutral$62.50 ➝ $67.00Low
7/25/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$68.00 ➝ $69.00Medium
7/25/2018Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$67.50 ➝ $72.50Medium
7/24/2018Bank of AmericaBoost TargetBuy ➝ Buy$72.50 ➝ $79.00Medium
7/23/2018BarclaysInitiated CoverageOverweight$79.00Low
7/18/2018CitigroupReiterated RatingNeutral$73.50Low
7/13/2018Morgan StanleyBoost TargetOverweight$63.50 ➝ $68.00Low
6/18/2018OppenheimerBoost Target$65.00 ➝ $69.00Low
6/18/2018Credit Suisse GroupBoost TargetNeutral ➝ Neutral$56.00 ➝ $62.50Medium
6/18/2018BMO Capital MarketsBoost TargetPositive ➝ Outperform$75.00Low
6/18/2018SVB LeerinkBoost TargetMarket Perform$60.00 ➝ $65.00Medium
6/18/2018Cantor FitzgeraldBoost TargetOverweight$68.50Medium
6/18/2018Wells Fargo & CompanyBoost TargetOutperform$63.00 ➝ $71.00Medium
4/25/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$63.00 ➝ $63.50Low
4/2/2018Cantor FitzgeraldReiterated RatingBuy$62.50Low
3/26/2018BMO Capital MarketsReiterated RatingBuyLow
2/13/2018SVB LeerinkReiterated RatingMarket Perform ➝ Market Perform$50.00 ➝ $45.00Low
2/7/2018Credit Suisse GroupBoost TargetNeutral ➝ Neutral$55.00 ➝ $56.00Low
2/7/2018Cantor FitzgeraldBoost TargetBuy ➝ Overweight$57.50 ➝ $62.50Low
2/7/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$59.00 ➝ $63.00Medium
2/7/2018CitigroupReiterated RatingOutperform$61.00 ➝ $65.00Low
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy$67.50Medium
12/20/2017OppenheimerBoost TargetOutperform$55.50 ➝ $61.00Low
12/18/2017Jefferies Financial GroupBoost TargetBuy ➝ Buy$56.00 ➝ $57.50Medium
12/18/2017Piper Jaffray CompaniesReiterated RatingBuy$67.00High
12/18/2017Cantor FitzgeraldReiterated RatingBuy$57.50High
12/15/2017OppenheimerReiterated RatingBuy$55.50High
11/8/2017OppenheimerReiterated RatingBuy$55.50N/A
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$51.00N/A
10/25/2017OppenheimerBoost TargetOutperform$52.50 ➝ $55.50N/A
10/24/2017OppenheimerReiterated RatingBuy$52.50N/A
10/24/2017Cantor FitzgeraldReiterated RatingBuy$53.50N/A
10/24/2017CowenReiterated RatingBuy$57.50N/A
10/17/2017BMO Capital MarketsInitiated CoverageOutperform$60.00N/A
10/13/2017Jefferies Financial GroupBoost TargetBuy$49.00 ➝ $56.00N/A
(Data available from 10/1/2017 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 14 very positive mentions
  • 32 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 8 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
  • 8 very positive mentions
  • 30 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
  • 10 very positive mentions
  • 31 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 10 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
  • 18 very positive mentions
  • 22 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
  • 9 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
  • 13 very positive mentions
  • 16 positive mentions
  • 5 negative mentions
  • 1 very negative mentions

Current Sentiment

  • 13 very positive mentions
  • 16 positive mentions
  • 5 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Centene logo
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Read More

Today's Range

Now: $77.81
Low: $77.52
High: $79.53

50 Day Range

MA: $89.84
Low: $77.30
High: $97.22

52 Week Range

Now: $77.81
Low: $60.81
High: $98.53


4,697,830 shs

Average Volume

4,501,966 shs

Market Capitalization

$44.47 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?

The following equities research analysts have issued stock ratings on Centene in the last twelve months: Argus, Bank of America Co., Barclays PLC, BMO Capital Markets, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., Loop Capital, Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Sanford C. Bernstein, Stephens, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for CNC.

What is the current price target for Centene?

20 Wall Street analysts have set twelve-month price targets for Centene in the last year. Their average twelve-month price target is $98.20, suggesting a possible upside of 26.2%. Jefferies Financial Group Inc. has the highest price target set, predicting CNC will reach $115.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $77.00 for Centene in the next year.
View the latest price targets for CNC.

What is the current consensus analyst rating for Centene?

Centene currently has 5 hold ratings and 13 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CNC will outperform the market and that investors should add to their positions of Centene.
View the latest ratings for CNC.

What other companies compete with Centene?

How do I contact Centene's investor relations team?

Centene's physical mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company's listed phone number is (314) 725-4477 and its investor relations email address is [email protected] The official website for Centene is www.centene.com. Learn More about contacing Centene investor relations.